Wacker Chemie Ag · XETR:WCH

Wacker Chemie — Wacker Chemie Ag Ord — FY2023 Earnings Presentation

22 slides from Wacker Chemie's earnings presentation, Mar 12, 2024

  1. Slide 1: FY 2023 – Conference Call Note

    CREATING TOMORROW’S SOLUTIONS FY 2023 – Conference Call Note Dr. Christian Hartel (CEO), Dr. Tobias Ohler (CFO) March 12, 2024 FY 2023 – Conference Call Note March 12, 2024 0

  2. Slide 2: Disclaimer

    Disclaimer The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on man

  3. Slide 3: WACKER FY 2023 Highlights

    WACKER FY 2023 Highlights Financials Operations Sustainability €6.4bn Continued Headwinds CDP Rating: Top Persistently high energy, raw material Score on Sales (-22% yoy) Driven primarily by lower ASPs and volumes costs, reduced utilization, lower ASPs Climate Change WACKER rated with an €824m €327m

  4. Slide 4: FY 2024 Group Guidance – Committed to 2030 Targets

    FY 2024 Group Guidance – Committed to 2030 Targets Outlook for FY 2024 FY 2024 Group Guidance  Sales of €6,000 – 6,500m  EBITDA of €600 – 800m  CapEx slightly below FY 2023 INVESTING IN THE FUTURE PEOPLE Investing in the Future: Committed to 2030 Targets MARKETS MOLECULES  Sales: > €10bn  EBITD

  5. Slide 5: Strategic Investments for Future Growth Supported by Mega-Trends

    Strategic Investments for Future Growth Supported by Mega-Trends SILICONES POLYMERS BIOSOLUTIONS POLYSILICON Burghausen & Nünchritz Calvert City: Halle: Burghausen:  Intermediates, Hybrids  VAE Dispersions  mRNA Competence  Semiconductor Etching  Completion: 2024-25  Completion: 2025 Center 

  6. Slide 6: Investing in the Future: People, Markets, Molecules

    Investing in the Future: People, Markets, Molecules People Markets Molecules  Employees are the foundation to  In the Regions for the Regions –  Solutions for a better future – our success operations in all growth markets enabling resource saving around the world technologies  Growth in the numb

  7. Slide 7: €824m in EBITDA in a Continued Weak Demand Environment

    Profit & Loss Statement €824m in EBITDA in a Continued Weak Demand Environment Profit & Loss (€m) Sales Bridge (€m) -22% FY 2023 FY 2022 8,209 -655 -1,028 6,402 -124 Sales 6,402 8,209 Gross profit from sales 1,083 2,161 Sales Volume/Mix Price FX Sales Gross margin 16.9% 26.3% FY 2022 FY 2023 EBITDA

  8. Slide 8: Resilient Financials with €4.6bn in Equity and €1.4bn in Liquidity

    Balance Sheet Composition Resilient Financials with €4.6bn in Equity and €1.4bn in Liquidity Balance sheet (%) Characteristics 12/31/23 Assets Liabilities  Cash & Securities: High level of liquidity at €1.4bn €9.4bn €8.9bn €9.4bn €8.9bn  Working Capital: -€330m lower yoy on release from inventorie

  9. Slide 9: Silicones: FY EBITDA of €236m, Driven by Weak Demand

    SILICONES FY EBITDA of €236m, Driven by Weak Demand, Low Prices and Adverse Mix Effects Sales (€m) 2023 Comments -14% -21% 706 3,453  Weak demand across all regions, with year-end seasonality 610 2,741  Low specialty volumes  Low standards prices, stabilizing at year-end Q4 2022 Q4 2023 FY 2022 F

  10. Slide 10: Polymers: FY EBITDA at €253m, Defending Margins

    POLYMERS FY EBITDA at €253m, Defending Margins in Weak Markets Sales (€m) 2023 Comments -19% -21%  Volumes below prior year level, with year-end seasonality 421 1,996 342 1,580  ASP lower yoy following development of raws & long market  Regions: Europe with weak market demand, Americas Q4 2022 Q4

  11. Slide 11: Biosolutions: FY EBITDA at €7m, Burdened by Upfront Costs

    BIOSOLUTIONS FY EBITDA at €7m, Burdened by Upfront Costs Sales (€m) 2023 Comments +14% +2%  Strong growth in BioPharma sales 81 93 331 337  EBITDA with upfront costs for the mRNA facility in Halle, integration costs from ADL acquisition Q4 2022 Q4 2023 FY 2022 FY 2023  Peak in CapEx driven by mRN

  12. Slide 12: Polysilicon: FY EBITDA at €321m, Solar With Significantly Lower Prices

    POLYSILICON FY EBITDA at €321m, Solar With Significantly Lower Prices Sales (€m) 2023 Comments -30% -47% 2,287  Significantly lower solar ASPs and production-related 574 1,599 volume declines 303  Resilient Semi volumes with higher prices Q4 2022 Q4 2023 FY 2022 FY 2023  Ongoing solar price diffe

  13. Slide 13: Others: Quarterly EBITDA Strongly Influenced by CO2 Compensation

    OTHERS Quarterly EBITDA Strongly Influenced by CO2 Compensation Sales (€m) 2023 Comments -22%  In Q4/23, CO2 compensation for the FY 2023 of approx. 50 45 38 40 39 €100m was received and recognized as income in the OTHERS segment Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Modeling Help  To ensure a t

  14. Slide 14: €936m Gross Cash Flow Supported By Release from Working Capital

    Net Financial Position €936m Gross Cash Flow Supported By Release from Working Capital Net Financial Position Bridge per 12/31/2023 (€m) 936 409 -771 -596 -23 -39 -84 Net financial asset Cash flow Cash flow from Dividend Lease Exchange-rate Net financial debt as of from operating long-term paid, lia

  15. Slide 15: Q1 Trading Update

    Q1 Trading Update Sales of about €1.5bn with an EBITDA at the Level of Q4/23 at about €135m SILICONES POLYMERS  Sales and EBITDA sequentially higher  Sales and EBITDA sequentially higher  Continued low ASP for Standards  Q1 benefits from seasonality  Improved order intake so far  Demand from c

  16. Slide 16: FY 2023 – Q&A Session

    FY 2023 – Q&A Session FY 2023 – Conference Call Note March 12, 2024 15

  17. Slide 17: Guidance FY 2024

    Appendix Guidance FY 2024 In €m FY 2023 Outlook 2024 Sales 6,402 €6,000 – 6,500m EBITDA 824 €600 – 800m EBITDA margin (%) 12.9 Substantially lower than last year Net cash flow 166 Negative, substantially lower than last year CapEx 710 Slightly lower than last year Net Debt 84 Higher than last year N

  18. Slide 18: Progress Made on Achieving Ambitious Group Sustainability Targets

    Appendix Progress Made on Achieving Ambitious Group Sustainability Targets 2020 2021 2022 2023 2030 Target Net Zero 100% 93% 87% 72% 100% reduction by 2045 Value Up Sustainable products 83% 89% 90% 94% 100% of products meet defined sustainability criteria Diversity: Woman in management 17% 19% 21% 2

  19. Slide 19: FY 2023 Results – Breakdown by Business

    Appendix FY 2023 Results – Breakdown by Business FY 2023 FY 2022 Q4 2023 Q4 2022 EBITDA EBITDA EBITDA EBITDA In €m / % SALES EBITDA MARGIN SALES EBITDA MARGIN SALES EBITDA MARGIN SALES EBITDA MARGIN Chemicals 4,321 490 11.3 5,449 1,165 21.4 952 69 7.3 1,128 168 14.9 SILICONES 2,741 236 8.6 3,453 876

  20. Slide 20: Strong Growth of Global PV Markets in 2024 Expected

    Appendix Strong Growth of Global PV Markets in 2024 Expected Country 2020 2021 2022 2023 2024 Germany 5 5 8 14 14 - 18 Spain 3 4 8 8 8 - 10 Europe other 13 20 30 35 38 - 52 Europe total 21 29 45 57 60 - 80 USA 19 25 19 33 35 - 55 Japan 8 8 7 7 6-8 China 48 55 87 217 230 - 250 India 4 12 14 10 15 - 2

  21. Slide 21: Key Raw Materials, Power and Gas

    Appendix Key Raw Materials, Power and Gas Si-Metal (€/mt) Electricity (€/MWh) 10,000 500 8,000 400 6,000 300 4,000 200 2,000 100 0 0 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 Source: CRU, Si-Metal Spot FD Europe Source: EEX, Baseload Front Contract Avg. Month VAM (€/mt) Natural Gas (€/MWh) 4

  22. Slide 22: WACKER: Issuer, Contact and Additional Information

    WACKER: Issuer, Contact and Additional Information Issuer and Contact Financial Calendar INVESTOR RELATIONS CONTACTS 04/25/24 Q1 2024 Results 05/08/24 Annual General Meeting, Munich Joerg Hoffmann, CFA 07/26/24 Q2 2024 Results Tel. +49 89 6279 1633 | joerg.hoffmann@wacker.com 09/18+19/24 CMD Burghau

Wacker Chemie Ag Ord — FY2023 Earnings Presentation on 6ix